The novel Kv1.5 channel blocker vernakalant for successful treatment of new-onset atrial fibrillation in a critically ill abdominal surgical patient.

Molecular Basis of Cardiac Delayed Rectifier Potassium Channel Function and Pharmacology. Card Electrophysiol Clin (2016) 0.78

The vernakalant story: how did it come to approval in Europe and what is the delay in the U.S.A? Curr Cardiol Rev (2014) 0.77

Suitability, efficacy, and safety of vernakalant for new onset atrial fibrillation in critically ill patients. Crit Care Res Pract (2014) 0.75

Letrozole, a new oral aromatase inhibitor: randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer. Letrozole International Trial Group (AR/BC3). Ann Oncol (1998) 1.01

Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients. Minerva Med (2012) 0.95

Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II study. J Clin Oncol (1990) 0.86

[Public access defibrillation. Limited use by trained first responders and laymen]. Anaesthesist (2006) 0.80

[Fast-track surgery in radical retropubic prostatectomy. First experiences with a comprehensive program to enhance postoperative convalescence]. Urologe A (2005) 0.78

Detoxification enzymes in the duodenal mucosa of patients with familial adenomatous polyposis. Br J Surg (2005) 0.78

[Perioperative pharmacological myocardial protection. Systematic literature-based process optimization]. Anaesthesist (2008) 0.77

Inhibition of HERG channels by the local anaesthetic articaine. Eur J Anaesthesiol (2006) 0.77

Loss of propofol during in vitro experiments. Anesthesiology (2000) 0.77

Ketamine effects on human neuronal Na+ channels. Eur J Anaesthesiol (2002) 0.76

Anesthetic mechanisms in-vitro and in general anesthesia. Toxicol Lett (1998) 0.76

[Severe accidental hypothermia with cardiac arrest and extracorporeal rewarming. A case report of a 2-year-old child]. Anaesthesist (2007) 0.75

[Perioperative treatment of patients with long QT syndrome]. Anaesthesist (2015) 0.75

[Long QT syndrome. History, genetics, clinical symptoms, causes and therapy]. Anaesthesist (2015) 0.75

[Improved survival by guideline compliant cardiopulmonary resuscitation: analysis of primary survival rates in the Hamburg emergency medical service]. Anaesthesist (2010) 0.75

Automated perioperative QT monitoring in a patient with long QT syndrome 2. Br J Anaesth (2010) 0.75

[Severe anaphylaxis from rocuronium]. Anaesthesist (2006) 0.75

[Invasive actinomycosis in a patient with ten year intrauterine polyps]. Rofo (2004) 0.75

[Perioperative monitoring of the QT interval]. Anaesthesist (2010) 0.75

[Thalidomide for the treatment of recurrent gastrointestinal blood loss due to intestinal angiodysplasias]. Ned Tijdschr Geneeskd (2006) 0.75